nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefixime—SLC22A5—Dactinomycin—sarcoma	0.699	1	CbGbCtD
Cefixime—Nephropathy toxic—Mitoxantrone—sarcoma	0.00659	0.0219	CcSEcCtD
Cefixime—Nephropathy toxic—Etoposide—sarcoma	0.00548	0.0182	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Thiotepa—sarcoma	0.00482	0.016	CcSEcCtD
Cefixime—Blood bilirubin increased—Thiotepa—sarcoma	0.00464	0.0154	CcSEcCtD
Cefixime—Colitis—Thiotepa—sarcoma	0.00421	0.014	CcSEcCtD
Cefixime—Aplastic anaemia—Dactinomycin—sarcoma	0.00409	0.0136	CcSEcCtD
Cefixime—Blood bilirubin increased—Mitoxantrone—sarcoma	0.004	0.0133	CcSEcCtD
Cefixime—Lactic dehydrogenase activity increased—Epirubicin—sarcoma	0.00345	0.0114	CcSEcCtD
Cefixime—Lactic dehydrogenase activity increased—Doxorubicin—sarcoma	0.00319	0.0106	CcSEcCtD
Cefixime—Blood lactate dehydrogenase increased—Epirubicin—sarcoma	0.00304	0.0101	CcSEcCtD
Cefixime—Candida infection—Etoposide—sarcoma	0.00301	0.00998	CcSEcCtD
Cefixime—Renal failure acute—Mitoxantrone—sarcoma	0.00298	0.00988	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00284	0.00944	CcSEcCtD
Cefixime—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00284	0.00942	CcSEcCtD
Cefixime—Thrombocytosis—Epirubicin—sarcoma	0.00284	0.00942	CcSEcCtD
Cefixime—Blood lactate dehydrogenase increased—Doxorubicin—sarcoma	0.00281	0.00932	CcSEcCtD
Cefixime—Thrombocytosis—Doxorubicin—sarcoma	0.00263	0.00871	CcSEcCtD
Cefixime—Pancytopenia—Thiotepa—sarcoma	0.00261	0.00867	CcSEcCtD
Cefixime—Pancytopenia—Dactinomycin—sarcoma	0.00259	0.0086	CcSEcCtD
Cefixime—Neutropenia—Dactinomycin—sarcoma	0.00255	0.00847	CcSEcCtD
Cefixime—Blister—Epirubicin—sarcoma	0.00245	0.00813	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00241	0.00801	CcSEcCtD
Cefixime—Renal failure—Thiotepa—sarcoma	0.00241	0.008	CcSEcCtD
Cefixime—Jaundice—Thiotepa—sarcoma	0.00239	0.00793	CcSEcCtD
Cefixime—Anaphylactoid reaction—Etoposide—sarcoma	0.00236	0.00784	CcSEcCtD
Cefixime—Pancytopenia—Vincristine—sarcoma	0.00232	0.00769	CcSEcCtD
Cefixime—Agranulocytosis—Thiotepa—sarcoma	0.00229	0.00759	CcSEcCtD
Cefixime—Neutropenia—Vincristine—sarcoma	0.00228	0.00757	CcSEcCtD
Cefixime—Agranulocytosis—Dactinomycin—sarcoma	0.00227	0.00754	CcSEcCtD
Cefixime—Blister—Doxorubicin—sarcoma	0.00227	0.00752	CcSEcCtD
Cefixime—Pancytopenia—Mitoxantrone—sarcoma	0.00226	0.00748	CcSEcCtD
Cefixime—Neutropenia—Mitoxantrone—sarcoma	0.00222	0.00737	CcSEcCtD
Cefixime—Haemoglobin—Thiotepa—sarcoma	0.00221	0.00734	CcSEcCtD
Cefixime—Haemorrhage—Thiotepa—sarcoma	0.0022	0.0073	CcSEcCtD
Cefixime—Hepatitis—Dactinomycin—sarcoma	0.00219	0.00725	CcSEcCtD
Cefixime—Renal failure—Mitoxantrone—sarcoma	0.00208	0.00691	CcSEcCtD
Cefixime—Erythema multiforme—Dactinomycin—sarcoma	0.00207	0.00685	CcSEcCtD
Cefixime—Jaundice—Mitoxantrone—sarcoma	0.00206	0.00685	CcSEcCtD
Cefixime—Urinary tract infection—Mitoxantrone—sarcoma	0.00206	0.00683	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00206	0.00683	CcSEcCtD
Cefixime—Agranulocytosis—Mitoxantrone—sarcoma	0.00198	0.00656	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Epirubicin—sarcoma	0.00194	0.00644	CcSEcCtD
Cefixime—Haemoglobin—Mitoxantrone—sarcoma	0.00191	0.00634	CcSEcCtD
Cefixime—Haemorrhage—Mitoxantrone—sarcoma	0.0019	0.00631	CcSEcCtD
Cefixime—Hepatitis—Mitoxantrone—sarcoma	0.0019	0.00631	CcSEcCtD
Cefixime—Pancytopenia—Etoposide—sarcoma	0.00188	0.00623	CcSEcCtD
Cefixime—Blood bilirubin increased—Epirubicin—sarcoma	0.00187	0.00619	CcSEcCtD
Cefixime—Neutropenia—Etoposide—sarcoma	0.00185	0.00613	CcSEcCtD
Cefixime—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.0018	0.00596	CcSEcCtD
Cefixime—Vaginal inflammation—Epirubicin—sarcoma	0.00177	0.00586	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00175	0.00579	CcSEcCtD
Cefixime—Renal failure—Etoposide—sarcoma	0.00173	0.00575	CcSEcCtD
Cefixime—Blood bilirubin increased—Doxorubicin—sarcoma	0.00173	0.00573	CcSEcCtD
Cefixime—Jaundice—Etoposide—sarcoma	0.00172	0.0057	CcSEcCtD
Cefixime—Leukopenia—Thiotepa—sarcoma	0.00172	0.00569	CcSEcCtD
Cefixime—Leukopenia—Dactinomycin—sarcoma	0.0017	0.00565	CcSEcCtD
Cefixime—Colitis—Epirubicin—sarcoma	0.0017	0.00562	CcSEcCtD
Cefixime—Candida infection—Epirubicin—sarcoma	0.00169	0.00559	CcSEcCtD
Cefixime—Vaginal infection—Epirubicin—sarcoma	0.00167	0.00553	CcSEcCtD
Cefixime—Convulsion—Thiotepa—sarcoma	0.00166	0.00551	CcSEcCtD
Cefixime—Aplastic anaemia—Epirubicin—sarcoma	0.00166	0.0055	CcSEcCtD
Cefixime—Agranulocytosis—Etoposide—sarcoma	0.00164	0.00545	CcSEcCtD
Cefixime—Vaginal inflammation—Doxorubicin—sarcoma	0.00163	0.00542	CcSEcCtD
Cefixime—Colitis—Doxorubicin—sarcoma	0.00157	0.0052	CcSEcCtD
Cefixime—Candida infection—Doxorubicin—sarcoma	0.00156	0.00517	CcSEcCtD
Cefixime—Vaginal infection—Doxorubicin—sarcoma	0.00154	0.00512	CcSEcCtD
Cefixime—Aplastic anaemia—Doxorubicin—sarcoma	0.00153	0.00509	CcSEcCtD
Cefixime—Thrombocytopenia—Thiotepa—sarcoma	0.00153	0.00508	CcSEcCtD
Cefixime—Leukopenia—Vincristine—sarcoma	0.00152	0.00505	CcSEcCtD
Cefixime—Thrombocytopenia—Dactinomycin—sarcoma	0.00152	0.00504	CcSEcCtD
Cefixime—Erythema multiforme—Etoposide—sarcoma	0.0015	0.00496	CcSEcCtD
Cefixime—Leukopenia—Mitoxantrone—sarcoma	0.00148	0.00492	CcSEcCtD
Cefixime—Convulsion—Vincristine—sarcoma	0.00147	0.00489	CcSEcCtD
Cefixime—Hepatic function abnormal—Epirubicin—sarcoma	0.00147	0.00486	CcSEcCtD
Cefixime—Convulsion—Mitoxantrone—sarcoma	0.00143	0.00476	CcSEcCtD
Cefixime—Renal failure acute—Epirubicin—sarcoma	0.00139	0.00461	CcSEcCtD
Cefixime—Anaphylactic shock—Vincristine—sarcoma	0.00139	0.0046	CcSEcCtD
Cefixime—Dyspepsia—Thiotepa—sarcoma	0.00138	0.00457	CcSEcCtD
Cefixime—Thrombocytopenia—Vincristine—sarcoma	0.00136	0.00451	CcSEcCtD
Cefixime—Hepatic function abnormal—Doxorubicin—sarcoma	0.00136	0.0045	CcSEcCtD
Cefixime—Anaphylactic shock—Mitoxantrone—sarcoma	0.00135	0.00448	CcSEcCtD
Cefixime—Renal impairment—Epirubicin—sarcoma	0.00135	0.00447	CcSEcCtD
Cefixime—Dermatitis bullous—Epirubicin—sarcoma	0.00134	0.00445	CcSEcCtD
Cefixime—Shock—Mitoxantrone—sarcoma	0.00133	0.00441	CcSEcCtD
Cefixime—Anaphylactoid reaction—Epirubicin—sarcoma	0.00132	0.00439	CcSEcCtD
Cefixime—Thrombocytopenia—Mitoxantrone—sarcoma	0.00132	0.00439	CcSEcCtD
Cefixime—Renal failure acute—Doxorubicin—sarcoma	0.00128	0.00426	CcSEcCtD
Cefixime—Gastrointestinal pain—Thiotepa—sarcoma	0.00128	0.00424	CcSEcCtD
Cefixime—Gastrointestinal pain—Dactinomycin—sarcoma	0.00127	0.00421	CcSEcCtD
Cefixime—Renal impairment—Doxorubicin—sarcoma	0.00125	0.00413	CcSEcCtD
Cefixime—Urticaria—Thiotepa—sarcoma	0.00124	0.00412	CcSEcCtD
Cefixime—Dermatitis bullous—Doxorubicin—sarcoma	0.00124	0.00412	CcSEcCtD
Cefixime—Face oedema—Epirubicin—sarcoma	0.00124	0.0041	CcSEcCtD
Cefixime—Abdominal pain—Thiotepa—sarcoma	0.00124	0.0041	CcSEcCtD
Cefixime—Body temperature increased—Thiotepa—sarcoma	0.00124	0.0041	CcSEcCtD
Cefixime—Leukopenia—Etoposide—sarcoma	0.00123	0.00409	CcSEcCtD
Cefixime—Abdominal pain—Dactinomycin—sarcoma	0.00123	0.00407	CcSEcCtD
Cefixime—Body temperature increased—Dactinomycin—sarcoma	0.00123	0.00407	CcSEcCtD
Cefixime—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00123	0.00406	CcSEcCtD
Cefixime—Convulsion—Etoposide—sarcoma	0.00119	0.00396	CcSEcCtD
Cefixime—Dyspepsia—Mitoxantrone—sarcoma	0.00119	0.00395	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00115	0.00383	CcSEcCtD
Cefixime—Hypersensitivity—Thiotepa—sarcoma	0.00115	0.00382	CcSEcCtD
Cefixime—Face oedema—Doxorubicin—sarcoma	0.00114	0.0038	CcSEcCtD
Cefixime—Hypersensitivity—Dactinomycin—sarcoma	0.00114	0.00379	CcSEcCtD
Cefixime—Gastrointestinal pain—Vincristine—sarcoma	0.00113	0.00376	CcSEcCtD
Cefixime—Anaphylactic shock—Etoposide—sarcoma	0.00112	0.00373	CcSEcCtD
Cefixime—Pruritus—Thiotepa—sarcoma	0.00111	0.00367	CcSEcCtD
Cefixime—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0011	0.00366	CcSEcCtD
Cefixime—Thrombocytopenia—Etoposide—sarcoma	0.0011	0.00365	CcSEcCtD
Cefixime—Eosinophilia—Epirubicin—sarcoma	0.0011	0.00364	CcSEcCtD
Cefixime—Abdominal pain—Vincristine—sarcoma	0.0011	0.00364	CcSEcCtD
Cefixime—Body temperature increased—Vincristine—sarcoma	0.0011	0.00364	CcSEcCtD
Cefixime—Urticaria—Mitoxantrone—sarcoma	0.00107	0.00356	CcSEcCtD
Cefixime—Diarrhoea—Thiotepa—sarcoma	0.00107	0.00355	CcSEcCtD
Cefixime—Abdominal pain—Mitoxantrone—sarcoma	0.00107	0.00354	CcSEcCtD
Cefixime—Body temperature increased—Mitoxantrone—sarcoma	0.00107	0.00354	CcSEcCtD
Cefixime—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00107	0.00354	CcSEcCtD
Cefixime—Diarrhoea—Dactinomycin—sarcoma	0.00106	0.00352	CcSEcCtD
Cefixime—Pancytopenia—Epirubicin—sarcoma	0.00105	0.00349	CcSEcCtD
Cefixime—Neutropenia—Epirubicin—sarcoma	0.00104	0.00344	CcSEcCtD
Cefixime—Dizziness—Thiotepa—sarcoma	0.00103	0.00343	CcSEcCtD
Cefixime—Hypersensitivity—Vincristine—sarcoma	0.00102	0.00339	CcSEcCtD
Cefixime—Eosinophilia—Doxorubicin—sarcoma	0.00101	0.00337	CcSEcCtD
Cefixime—Hypersensitivity—Mitoxantrone—sarcoma	0.000995	0.0033	CcSEcCtD
Cefixime—Vomiting—Thiotepa—sarcoma	0.000995	0.0033	CcSEcCtD
Cefixime—Vomiting—Dactinomycin—sarcoma	0.000987	0.00327	CcSEcCtD
Cefixime—Rash—Thiotepa—sarcoma	0.000986	0.00327	CcSEcCtD
Cefixime—Dermatitis—Thiotepa—sarcoma	0.000985	0.00327	CcSEcCtD
Cefixime—Headache—Thiotepa—sarcoma	0.00098	0.00325	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000979	0.00325	CcSEcCtD
Cefixime—Rash—Dactinomycin—sarcoma	0.000979	0.00325	CcSEcCtD
Cefixime—Pancytopenia—Doxorubicin—sarcoma	0.000973	0.00323	CcSEcCtD
Cefixime—Renal failure—Epirubicin—sarcoma	0.000971	0.00322	CcSEcCtD
Cefixime—Jaundice—Epirubicin—sarcoma	0.000963	0.00319	CcSEcCtD
Cefixime—Urinary tract infection—Epirubicin—sarcoma	0.00096	0.00318	CcSEcCtD
Cefixime—Neutropenia—Doxorubicin—sarcoma	0.000958	0.00318	CcSEcCtD
Cefixime—Diarrhoea—Vincristine—sarcoma	0.000949	0.00315	CcSEcCtD
Cefixime—Nausea—Thiotepa—sarcoma	0.000929	0.00308	CcSEcCtD
Cefixime—Diarrhoea—Mitoxantrone—sarcoma	0.000924	0.00307	CcSEcCtD
Cefixime—Nausea—Dactinomycin—sarcoma	0.000922	0.00306	CcSEcCtD
Cefixime—Agranulocytosis—Epirubicin—sarcoma	0.000922	0.00306	CcSEcCtD
Cefixime—Gastrointestinal pain—Etoposide—sarcoma	0.000919	0.00305	CcSEcCtD
Cefixime—Dizziness—Vincristine—sarcoma	0.000917	0.00304	CcSEcCtD
Cefixime—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000906	0.00301	CcSEcCtD
Cefixime—Renal failure—Doxorubicin—sarcoma	0.000898	0.00298	CcSEcCtD
Cefixime—Urticaria—Etoposide—sarcoma	0.000893	0.00296	CcSEcCtD
Cefixime—Haemoglobin—Epirubicin—sarcoma	0.000891	0.00296	CcSEcCtD
Cefixime—Jaundice—Doxorubicin—sarcoma	0.000891	0.00295	CcSEcCtD
Cefixime—Body temperature increased—Etoposide—sarcoma	0.000888	0.00295	CcSEcCtD
Cefixime—Abdominal pain—Etoposide—sarcoma	0.000888	0.00295	CcSEcCtD
Cefixime—Urinary tract infection—Doxorubicin—sarcoma	0.000888	0.00295	CcSEcCtD
Cefixime—Haemorrhage—Epirubicin—sarcoma	0.000887	0.00294	CcSEcCtD
Cefixime—Hepatitis—Epirubicin—sarcoma	0.000887	0.00294	CcSEcCtD
Cefixime—Vomiting—Vincristine—sarcoma	0.000882	0.00293	CcSEcCtD
Cefixime—Rash—Vincristine—sarcoma	0.000875	0.0029	CcSEcCtD
Cefixime—Dermatitis—Vincristine—sarcoma	0.000874	0.0029	CcSEcCtD
Cefixime—Headache—Vincristine—sarcoma	0.000869	0.00288	CcSEcCtD
Cefixime—Vomiting—Mitoxantrone—sarcoma	0.000859	0.00285	CcSEcCtD
Cefixime—Agranulocytosis—Doxorubicin—sarcoma	0.000853	0.00283	CcSEcCtD
Cefixime—Rash—Mitoxantrone—sarcoma	0.000852	0.00283	CcSEcCtD
Cefixime—Dermatitis—Mitoxantrone—sarcoma	0.000851	0.00282	CcSEcCtD
Cefixime—Headache—Mitoxantrone—sarcoma	0.000846	0.00281	CcSEcCtD
Cefixime—Erythema multiforme—Epirubicin—sarcoma	0.000838	0.00278	CcSEcCtD
Cefixime—Hypersensitivity—Etoposide—sarcoma	0.000828	0.00275	CcSEcCtD
Cefixime—Haemoglobin—Doxorubicin—sarcoma	0.000825	0.00274	CcSEcCtD
Cefixime—Nausea—Vincristine—sarcoma	0.000824	0.00273	CcSEcCtD
Cefixime—Hepatitis—Doxorubicin—sarcoma	0.00082	0.00272	CcSEcCtD
Cefixime—Haemorrhage—Doxorubicin—sarcoma	0.00082	0.00272	CcSEcCtD
Cefixime—Nausea—Mitoxantrone—sarcoma	0.000802	0.00266	CcSEcCtD
Cefixime—Pruritus—Etoposide—sarcoma	0.000795	0.00264	CcSEcCtD
Cefixime—Erythema multiforme—Doxorubicin—sarcoma	0.000776	0.00257	CcSEcCtD
Cefixime—Diarrhoea—Etoposide—sarcoma	0.000769	0.00255	CcSEcCtD
Cefixime—Flatulence—Epirubicin—sarcoma	0.000761	0.00252	CcSEcCtD
Cefixime—Dizziness—Etoposide—sarcoma	0.000743	0.00247	CcSEcCtD
Cefixime—Vomiting—Etoposide—sarcoma	0.000714	0.00237	CcSEcCtD
Cefixime—Rash—Etoposide—sarcoma	0.000709	0.00235	CcSEcCtD
Cefixime—Dermatitis—Etoposide—sarcoma	0.000708	0.00235	CcSEcCtD
Cefixime—Headache—Etoposide—sarcoma	0.000704	0.00234	CcSEcCtD
Cefixime—Flatulence—Doxorubicin—sarcoma	0.000704	0.00233	CcSEcCtD
Cefixime—Leukopenia—Epirubicin—sarcoma	0.000691	0.00229	CcSEcCtD
Cefixime—Convulsion—Epirubicin—sarcoma	0.000669	0.00222	CcSEcCtD
Cefixime—Nausea—Etoposide—sarcoma	0.000667	0.00221	CcSEcCtD
Cefixime—Leukopenia—Doxorubicin—sarcoma	0.000639	0.00212	CcSEcCtD
Cefixime—Anaphylactic shock—Epirubicin—sarcoma	0.00063	0.00209	CcSEcCtD
Cefixime—Shock—Epirubicin—sarcoma	0.00062	0.00206	CcSEcCtD
Cefixime—Convulsion—Doxorubicin—sarcoma	0.000619	0.00205	CcSEcCtD
Cefixime—Thrombocytopenia—Epirubicin—sarcoma	0.000617	0.00205	CcSEcCtD
Cefixime—Anaphylactic shock—Doxorubicin—sarcoma	0.000583	0.00193	CcSEcCtD
Cefixime—Shock—Doxorubicin—sarcoma	0.000573	0.0019	CcSEcCtD
Cefixime—Thrombocytopenia—Doxorubicin—sarcoma	0.000571	0.00189	CcSEcCtD
Cefixime—Dyspepsia—Epirubicin—sarcoma	0.000554	0.00184	CcSEcCtD
Cefixime—Gastrointestinal pain—Epirubicin—sarcoma	0.000515	0.00171	CcSEcCtD
Cefixime—Dyspepsia—Doxorubicin—sarcoma	0.000513	0.0017	CcSEcCtD
Cefixime—Urticaria—Epirubicin—sarcoma	0.0005	0.00166	CcSEcCtD
Cefixime—Body temperature increased—Epirubicin—sarcoma	0.000498	0.00165	CcSEcCtD
Cefixime—Abdominal pain—Epirubicin—sarcoma	0.000498	0.00165	CcSEcCtD
Cefixime—Gastrointestinal pain—Doxorubicin—sarcoma	0.000477	0.00158	CcSEcCtD
Cefixime—Hypersensitivity—Epirubicin—sarcoma	0.000464	0.00154	CcSEcCtD
Cefixime—Urticaria—Doxorubicin—sarcoma	0.000463	0.00154	CcSEcCtD
Cefixime—Abdominal pain—Doxorubicin—sarcoma	0.000461	0.00153	CcSEcCtD
Cefixime—Body temperature increased—Doxorubicin—sarcoma	0.000461	0.00153	CcSEcCtD
Cefixime—Pruritus—Epirubicin—sarcoma	0.000446	0.00148	CcSEcCtD
Cefixime—Diarrhoea—Epirubicin—sarcoma	0.000431	0.00143	CcSEcCtD
Cefixime—Hypersensitivity—Doxorubicin—sarcoma	0.000429	0.00142	CcSEcCtD
Cefixime—Dizziness—Epirubicin—sarcoma	0.000417	0.00138	CcSEcCtD
Cefixime—Pruritus—Doxorubicin—sarcoma	0.000412	0.00137	CcSEcCtD
Cefixime—Vomiting—Epirubicin—sarcoma	0.0004	0.00133	CcSEcCtD
Cefixime—Diarrhoea—Doxorubicin—sarcoma	0.000399	0.00132	CcSEcCtD
Cefixime—Rash—Epirubicin—sarcoma	0.000397	0.00132	CcSEcCtD
Cefixime—Dermatitis—Epirubicin—sarcoma	0.000397	0.00132	CcSEcCtD
Cefixime—Headache—Epirubicin—sarcoma	0.000395	0.00131	CcSEcCtD
Cefixime—Dizziness—Doxorubicin—sarcoma	0.000385	0.00128	CcSEcCtD
Cefixime—Nausea—Epirubicin—sarcoma	0.000374	0.00124	CcSEcCtD
Cefixime—Vomiting—Doxorubicin—sarcoma	0.000371	0.00123	CcSEcCtD
Cefixime—Rash—Doxorubicin—sarcoma	0.000367	0.00122	CcSEcCtD
Cefixime—Dermatitis—Doxorubicin—sarcoma	0.000367	0.00122	CcSEcCtD
Cefixime—Headache—Doxorubicin—sarcoma	0.000365	0.00121	CcSEcCtD
Cefixime—Nausea—Doxorubicin—sarcoma	0.000346	0.00115	CcSEcCtD
